Finanical Statements
Macro Group Pharmaceuticals -Macro Capital (MCRO.CA) Reports 6 Months Consolidated Results
Published at 13 August 2026 at 12:20Macro Group Pharmaceuticals -Macro CapitalRelated stock:Macro Group Pharmaceuticals -Macro Capital stockAll Macro Group Pharmaceuticals -Macro Capital disclosures
Disclosure summary
Company Name : Macro Group Pharmaceuticals -Macro Capital
ISIN Code : EGS7D971C011
Currency : EGP
F/S Consolidated Period : From 01/01/2026 To 30/06/2026
Net Profit : 84,419,221
F/S Consolidated Period : From 01/01/2025 To 30/06/2025
Net Comparative Profit : 68,924,776
Audit Status : Reviewed
Comment : Taking into consideration minority rights
Source : Macro Group Pharmaceuticals -Macro Capital
The Financial Statements in Arabic (3,113 KB)
The Financial Statements in English (4,231 KB)
ISIN Code : EGS7D971C011
Currency : EGP
F/S Consolidated Period : From 01/01/2026 To 30/06/2026
Net Profit : 84,419,221
F/S Consolidated Period : From 01/01/2025 To 30/06/2025
Net Comparative Profit : 68,924,776
Audit Status : Reviewed
Comment : Taking into consideration minority rights
Source : Macro Group Pharmaceuticals -Macro Capital
The Financial Statements in Arabic (3,113 KB)
The Financial Statements in English (4,231 KB)